Literature DB >> 12144188

Outcomes and prognostic factors after surgical resection of hypopharyngeal and cervical esophageal carcinomas.

Tadashi Nishimaki1, Tatsuo Kanda, Satoru Nakagawa, Shin-ichi Kosugi, Tadashi Tanabe, Katsuyoshi Hatakeyama.   

Abstract

Carcinomas of the hypopharynx and the cervical esophagus carry poor prognosis regardless of any treatment modality. To improve long-term survival, prognostic factors for overall survival after surgical resection of these tumors were investigated. Clinical and pathological data from 52 patients undergoing surgical resection for hypopharyngeal (n = 20) and cervical esophageal (n = 32) cancers were reviewed to assess treatment outcomes and prognostic factors. The in-hospital mortality and morbidity rates were 13.5% and 50%, respectively. The 5-year survival rate of the 52 patients was 31.2%. The depth of tumor invasion, quality of tumor clearance, gender of the patients, postoperative complications, and intramural metastasis were revealed by the univariate analysis to be significant prognostic factors. The first four of these factors were specified by the multivariate analysis as independent prognostic factors for overall survival. Complete clearance of loco-regional disease and prevention of postoperative complications are of particular importance for the improvement of long-term survival in patients with these cancers.

Entities:  

Mesh:

Year:  2002        PMID: 12144188

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  5 in total

1.  Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.

Authors:  Hiroshi Okamoto; Yusuke Taniyama; Tadashi Sakurai; Takahiro Heishi; Jin Teshima; Chiaki Sato; Shota Maruyama; Ken Ito; Yu Onodera; Takuro Konno-Kumagai; Hirotaka Ishida; Takashi Kamei
Journal:  Esophagus       Date:  2018-06-15       Impact factor: 4.230

2.  Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.

Authors:  Ethan B Ludmir; Manisha Palta; Xuefeng Zhang; Yuan Wu; Christopher G Willett; Brian G Czito
Journal:  J Gastrointest Oncol       Date:  2014-12

3.  Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure.

Authors:  Cai-Neng Cao; Jing-Wei Luo; Li Gao; Guo-Zhen Xu; Jun-Lin Yi; Xiao-Dong Huang; Kai Wang; Shi-Ping Zhang; Yuan Qu; Su-Yan Li; Jian-Ping Xiao; Zhong Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-26       Impact factor: 2.503

4.  Should the Supraclavicular Lymph Nodes be Considered Regional Lymph Nodes in Cervical Esophageal Cancer?

Authors:  Yoshihisa Numata; Tetsuya Abe; Eiji Higaki; Takahiro Hosoi; Hironori Fujieda; Takuya Nagao; Nobuhiro Hanai; Hidenori Suzuki; Daisuke Nishikawa; Keitaro Matsuo; Tsutomu Fujii; Yasuhiro Shimizu
Journal:  Ann Surg Oncol       Date:  2021-09-03       Impact factor: 5.344

5.  Clinicopathological features and surgical treatment of cervical oesophageal cancer.

Authors:  Shao-Bin Chen; Xi-Hong Yang; Hong-Rui Weng; Di-Tian Liu; Hua Li; Yu-Ping Chen
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.